1. Bentley SJ, Pearson DJ, Rix KJ. Food hypersensitivity in irritable
bowel syndrome. Lancet 1983;ii:295–7. 2. McKee AM, Prior A, Whorwell PJ. Exclusion diets in irritable bowel
syndrome: are they worthwhile? J Clin Gastroenterol 1987;9:526–8. 3. Farah DA, Calder I, Benson L, Mackenzie JF. Specific food intolerance:
its place as a cause of gastrointestinal symptoms. Gut 1985;26:164–8. 4. Alun Jones V, Shorthouse M, Workman E, Hunter JO. Food intolerance and
the irritable bowel. Lancet 1983; ii:633–4 [letter]. 5. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable
bowel syndrome. Lancet 1998;352:1187–9. 6. Alun Jones V, McLaughlan P, Shorthouse M, et al. Food intolerance: A
major factor in the pathogenesis of irritable bowel syndrome. Lancet
1982;ii:1115–7. 7. Smith MA, Youngs GR, Finn R. Food intolerance, atopy, and irritable
bowel syndrome. Lancet 1985;ii:1064 [letter]. 8. Parker TJ, Naylor SJ, Riordan AM, Hunter JO. Management of patients
with food intolerance in irritable bowel syndrome: the development and use of an exclusion
diet. J Hum Nutr Diet 1995;8:159–66. 9. Birtwistle S. Letter. Lancet 1983; II:634. 10. Paganelli R, Fagiolo U, Cancian M, et al. Intestinal permeability in
irritable bowel syndrome. Effect of diet and sodium cromoglycate administration. Ann
Allergy 1990;64:377–80. 11. Alun Jones V, McLaughlan P, Shorthouse M, et al. Food intolerance: A
major factor in the pathogenesis of irritable bowel syndrome. Lancet
1982;ii:1115–7. 12. Fernandez-Banares F, Esteve-Pardo M, de Leon R, et al. Sugar
malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol
1993;88:2044–50. 13. Manning AP, Heaton KW, Harvey RF, Uglow P. Wheat fibre and irritable
bowel syndrome. Lancet 1977;ii:417–8. 14. Hotz J, Plein K. Effectiveness of plantago seed husks in comparison
with wheat bran no stool frequency and manifestations of irritable colon syndrome with
constipation. Med Klin 1994;89:645–51. 15. Cann PA, Read NW, Holdsworth CD. What is the benefit of coarse wheat
bran in patients with irritable bowel syndrome? Gut 1984;25:168–73. 16. Arffmann S, Andersen JR, Hegnhoj J, et al. The effect of coarse wheat
bran in the irritable bowel syndrome. A double-blind cross-over study. Scand J
Gastroenterol 1985;20:295–8. 17. Soloft J, Krag B, Gudmand-Hoyer E, et al. A double-blind trial of the
effect of wheat bran on symptoms of irritable bowel syndrome. Lancet
1976;i:270–3. 18. Lucey MR, Clark ML, Lowndes J, Dawson AM. Is bran efficacious in
irritable bowel syndrome? A double blind placebo controlled crossover study. Gut
1987;28:221–5. 19. Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: time for
reappraisal. Lancet 1994;344:39–40. 20. Gaby AR. Commentary. Nutrition and Healing
1996;Feb:1,10–1 [review]. 21. Niec AM, Frankum B, Talley NJ. Are adverse food reactions linked to
irritable bowel syndrome? Am J Gastroenterol 1998;93:2184–90 [review]. 22. Bohmer CJ, Tuynman HA. The clinical relevance of lactose
malabsorption in irritable bowel syndrome. Eur J Gastroenterol Hepatol
1996;8:1013–6. 23. Cotterell CJ, Lee AJ, Hunter JO. Double-blind cross-over trial of
evening primrose oil in women with menstrually-related irritable bowel syndrome. In
Omega-6 Essential Fatty Acids: Pathophysiology and roles in clinical medicine, Alan R
Liss, New York, 1990, 421–6. 24. Ionescu G, Kiehl R, Wichmann-Kunz F, et al. Oral citrus seed extract
in atopic eczema: In vitro and in vivo studies on intestinal microflora. J Orthomol
Med 1990;5:155–8. 25. Hotz J, Plein K. Effectiveness of plantago seed husks in comparison
with wheat bran no stool frequency and manifestations of irritable colon syndrome with
constipation. Med Klin 1994;89:645–51. 26. Jalihal A, Kurian G. Ispaghula therapy in irritable bowel syndrome:
improvement in overall well-being is related to reduction in bowel dissatisfaction. J
Gastroenterol Hepatol 1990;5:507–13. 27. Prior A, Whorwell PJ. Double blind study of ispaghula irritable bowel
syndrome. Gut 1987;11:1510–3. 28. Leicester RJ, Hunt RH. Peppermint oil to reduce colonic spasm during
endoscopy. Lancet 1982;ii:989 [letter]. 29. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a
critical review and metaanalysis. Am J Gastroenterol 1998;93:1131–5. 30. Poynard T, Naveau S, Mory B, Chaput JC. Meta-analysis of smooth
muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther
1994;8:499–510. 31. Rees WD, Evans BK, Rhodes J. Treating irritable bowel syndrome with
peppermint oil. Br Med J 1979;2(6194):835–6. 32. Liu J-H, Chen G-H, Yeh H-Z, et al. Enteric-coated peppermint-oil
capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J
Gastroenterol 1997;32:765–8. 33. Dew MJ, Evans BK, Rhodes J. Peppermint oil for the irritable bowel
syndrome: A multi-center trial. Br J Clin Pract 1984;38:394–8. 34. Nash P, Gould SR, Barnardo DE. Peppermint oil does not relieve the
pain of irritable bowel syndrome. Br J Clin Pract 1986;40:292–3. 35. Rogers J, Tay HH, Misiewicz JJ. Peppermint oil. Lancet
1988;ii:98–9 [letter]. 36. May B Kuntz HD, Kieser M, Kohler S. Efficacy of a fixed
peppermint/caraway oil combination in non-ulcer dyspepsia. Arzneimittelforschung
1996;46:1149–53. 37. Friese J, Köhler S. Peppermint/caraway oil-fixed combination in
non-ulcer dyspepsia: equivalent efficacy of the drug combination in an enteric coated or
enteric soluble formula. Pharmazie 1999;54:210–5. 38. Madisch A, Heydenreich CJ, Wieland V, et al. Treatment of functional
dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to
cisapride. Arneimittlforschung 1999;49:925–32. 39. Westphal J, Hörning M, Leonhardt K. Phytotherapy in functional
abdominal complaints: Results of a clinical study with a preparation of several plants.
Phytomedicine 1996;2:285–91. 40. Bundy R, Walker AF, Middleton RW, et al. Artichoke leaf extract
reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy
volunteers suffering from concomitant dyspepsia: a subset analysis. J Altern Complement
Med 2004;10:667–9. 41. Achterrath-Tuckerman U, Kunde R, et al. Pharmacological
investigations with compounds of chamomile. V. Investigations on the spasmolytic effect of
compounds of chamomile and Kamillosan® on isolated guinea pig ileum. Planta Med
1980;39:38–50. 42. Bensoussan A, Talley NJ, Hing M, et al. Treatment of irritable bowel
syndrome with Chinese herbal medicine. A randomized controlled trial. JAMA
1998;280:1585–9. 43. Whitehead WE, Palsson OS. Is rectal pain sensitivity a biological
marker for irritable bowel syndrome: psychological influences on pain perception.
Gastroenterology 1998;115:1263–71. 44. Dancey CP, Taghavi M, Fox RJ. The relationship between daily stress
and symptoms of irritable bowel: a time-series approach. J Psychosom Res
1998;44:537–45. 45. Guthrie E, Creed F, Dawson D, Tomenson BG. AA controlled trial of
psychological treatment for the irritable bowel syndrome. Gastroenterology
1991;100:450–7. 46. Harvey RF. Individual and group hypnotherapy in treatment of
refractory irritable bowel syndrome. Lancet 1989;i:424–6. 47. Waxman D. The irritable bowel: a pathological or a psychological
syndrome? J R Soc Med 1988;81:718–20. 48. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life
and economic features of irritable bowel syndrome—the effect of hypnotherapy.
Aliment Pharmacol Ther 1996;10:91–5. 49. Pagon A. Treatment by traditional oriental medicine. Irritable bowel
syndrome. J Chin Med 1998;58:28–31. |